Medivir
Medivir to present at the Carnegie Healthcare Day
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that the company will present at the Carnegie Healthcare Day, today, March 13, at 10.50 CET.
CEO Jens Lindberg will present the company and final data from the recently finalized phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox).
The presentation will be available on Medivir’s website after the meeting.
Datum | 2025-03-13, kl 08:45 |
Källa | MFN |
